Get the Stockscreener App
19.42
0.56%
-0.11
After Hours:
19.42
Staar Surgical Co stock is traded at $19.42, with a volume of 970.77K.
It is down -0.56% in the last 24 hours and up +22.37% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$19.53
Open:
$19.72
24h Volume:
970.77K
Relative Volume:
0.86
Market Cap:
$942.48M
Revenue:
$341.22M
Net Income/Loss:
$21.78M
P/E Ratio:
44.14
EPS:
0.44
Net Cash Flow:
$26.30M
1W Performance:
+2.05%
1M Performance:
+22.37%
6M Performance:
-34.37%
1Y Performance:
-54.69%
1-Day Range:
$19.33
$19.98
1-Week Range:
$18.30
$20.36
52-Week Range:
$13.50
$49.86
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
19.42 | 942.48M | 341.22M | 21.78M | 26.30M | 0.44 |
|
ISRG
Intuitive Surgical Inc
|
536.51 | 189.75B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.75 | 48.62B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.22 | 48.37B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
245.04 | 35.18B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.27 | 16.46B | 3.90B | 392.30M | 288.10M | 1.95 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
The STAAR Surgical Company (NASDAQ:STAA) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo
Quarterly Snapshot: Quick and Current Ratios for Staar Surgical Co (STAA) - DWinneX
STAAR Surgical Company (NASDAQ:STAA) Q1 2025 Earnings Call Transcript - Insider Monkey
STAAR Surgical’s Earnings Call: Growth Amid Challenges - TipRanks
Staar Surgical Withdraws FY 2025 Guidance Amid Tariffs & Economic Uncertainty - Medical Device and Diagnostic industry
Staar Surgical (STAA) Price Target Raised by Canaccord Genuity | STAA Stock News - GuruFocus
Stifel maintains $20 target, Buy rating on STAAR Surgical stock - Investing.com
Stifel maintains $20 target, Buy rating on STAAR Surgical stock By Investing.com - Investing.com UK
STAAR Surgical projects significant China revenue rebound in Q3 2025 amid tariff mitigation and new product launch - MSN
Canaccord raises STAAR Surgical stock target to $20, maintains Hold By Investing.com - Investing.com Australia
Canaccord raises STAAR Surgical stock target to $20, maintains Hold - Investing.com
Canaccord Increases Price Target for Staar Surgical (STAA) Despite Challenging Q1 | STAA Stock News - GuruFocus
STAAR Surgical Q1 2025 Earnings Report - MarketBeat
Staar Surgical Co (STAA) Q1 2025 Earnings Call Highlights: Navigating Challenges and Optimizing ... - Yahoo Finance
STAAR Surgical Surpasses Wall Street Expectations Amid Revenue DropNews and Statistics - IndexBox
Staar Surgical Co (STAA) Q1 2025 Earnings Call Highlights: Navigating Challenges and Optimizing Growth Strategies - GuruFocus
STAAR Surgical earnings missed by $0.52, revenue topped estimates - Investing.com
Staar Surgical: Q1 Earnings Snapshot - Norwalk Hour
Earnings call transcript: STAAR Surgical misses Q1 2025 EPS forecast, stock dips - Investing.com
STAAR Surgical (NASDAQ:STAA) Exceeds Q1 Expectations - Yahoo
Staar Surgical (STAA) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
STAAR Surgical (STAA) Exceeds Q1 Revenue Forecasts Amid China Im - GuruFocus
STAAR Surgical misses Q1 estimates, withdraws outlook - Investing.com
STAAR Surgical misses Q1 estimates, withdraws outlook By Investing.com - Investing.com Canada
STAAR Surgical (STAA) Exceeds Q1 Revenue Forecasts Amid China Improvements | STAA Stock News - GuruFocus
STAAR Surgical Reports First Quarter 2025 Results - Yahoo Finance
Raymond James Financial Inc. Purchases Shares of 38,017 STAAR Surgical (NASDAQ:STAA) - Defense World
STAAR Surgical (STAA) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Staar Surgical Co (STAA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Sete News
STAAR Surgical (NASDAQ:STAA) Shares Acquired by LPL Financial LLC - Defense World
LPL Financial LLC Grows Stock Holdings in STAAR Surgical (NASDAQ:STAA) - American Banking and Market News
Staar Surgical Co (NASDAQ:STAA) Shares Surged 6.75% In A Week – But Can It Maintain Its Gains? - Marketing Sentinel
Press Release Distribution & PR Platform - ACCESS Newswire
Midday Stock Roundup: FivePoint Rises on Earnings - Orange County Business Journal
Investing in Staar Surgical Co (STAA) might be a great opportunity, but the stock is a bit overvalued - uspostnews.com
STAAR Surgical reshuffles board, boosts Asia Pacific focus - Investing.com Australia
STAAR Surgical Announces Changes To Board Of Directors - marketscreener.com
Staar Surgical Announces Board Changes and New Advisor - MSN
STAAR Surgical reshuffles board, boosts Asia Pacific focus By Investing.com - Investing.com India
STAAR Surgical Announces Changes to Board of Directors - Yahoo Finance
Adversity is less terrifying than hope: Staar Surgical Co (STAA) - Sete News
STAAR Surgical to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025 - Yahoo Finance
STAAR Surgical (NASDAQ:STAA) Now Covered by Wells Fargo & Company - Defense World
Wells Fargo Initiates STAAR Surgical at Equalweight With $17 Price Target - marketscreener.com
This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Wells Fargo Initiates Coverage of Staar Surgical (STAA) with Equ - GuruFocus
Wells Fargo Initiates Coverage of Staar Surgical (STAA) with Equal Weight Rating | STAA Stock News - GuruFocus
JPMorgan Chase & Co. Sells 48,102 Shares of STAAR Surgical (NASDAQ:STAA) - Defense World
STAAR Surgical (NASDAQ:STAA) Given Consensus Rating of “Hold” by Brokerages - Defense World
STAAR Surgical (NASDAQ:STAA) Shares Bought by American Century Companies Inc. - Defense World
Couchbase, Staar Surgical, Zymeworks, and More Stocks See Action From Activist Investors - MSN
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Staar Surgical Co Stock (STAA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 09 '25 |
Buy |
15.08 |
8,200 |
123,676 |
13,518,591 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 10 '25 |
Buy |
15.18 |
900 |
13,658 |
13,519,491 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 04 '25 |
Buy |
15.91 |
497,631 |
7,917,191 |
13,194,210 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 03 '25 |
Buy |
16.97 |
209,535 |
3,555,138 |
12,696,579 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 07 '25 |
Buy |
15.61 |
138,054 |
2,155,174 |
13,332,264 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 02 '25 |
Buy |
17.43 |
31,780 |
553,925 |
12,487,044 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Mar 31 '25 |
Buy |
17.46 |
22,189 |
387,360 |
12,455,264 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Mar 26 '25 |
Buy |
17.50 |
101,633 |
1,778,517 |
12,421,324 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Mar 28 '25 |
Buy |
17.47 |
8,131 |
142,014 |
12,433,075 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Mar 27 '25 |
Buy |
17.48 |
3,620 |
63,294 |
12,424,944 |
5.40%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):